We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 06, 2021

Omidubicel vs Standard Myeloablative Umbilical Cord Blood Transplantation



Additional Info

Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study
Blood 2021 Jun 22;[EPub Ahead of Print], ME Horwitz, PJ Stiff, CS Cutler, CG Brunstein, R Hanna, RT Maziarz, AR Rezvani, NA Karras, JP McGuirk, D Valcarcel, GJ Schiller, CA Lindemans, WY Hwang, LP Koh, AK Keating, Y Khaled, N Hamerschlak, O Frankfurt, T Peled, I Segalovich, B Blackwell, S Wease, LS Freedman, E Galamidi-Cohen, GF Sanz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading